Drug Discovery


Drug Discovery Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
2015 Market Research Report on Global Medical Oxygen Concentrator Industry

2015 Market Research Report on Global Medical Oxygen Concentrator Industry

Date Published: Mar 25 2015

2015 Market Research Report on Global Medical Oxygen Concentrator Industry is a professional and deep research report in this field.

For overview analysis, the report introduces Medical Oxygen Concentrator basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

$2,600.00
2015 Market Research Report on Global Cyanopyridine Industry

2015 Market Research Report on Global Cyanopyridine Industry

Date Published: Mar 24 2015

2015 Market Research Report on Global Cyanopyridine Industry is a professional and deep research report in this field.

For overview analysis, the report introduces Cyanopyridine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

$2,600.00
Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Date Published: Mar 6 2015

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2015 report provides an insight into the Indian Anti-Diabetic Pharmaceuticals current market scenario, structure and practices.

In depth market scenario includes;
- Current market size estimate
- Market size by players – Top Companies
- Market size by product categories – Oral Drugs and Insulin
- Market size by regions – North, South, East, West

$5,000.00
Opportunity in the Indian Anti-Infective Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Anti-Infective Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Date Published: Mar 6 2015

Opportunity in the Indian Anti-Infective Pharmaceuticals Market - 2015 report provides an insight into the Indian Anti-Infective Pharmaceuticals current market scenario, structure and practices.

In depth market scenario includes;
- Current market size estimate
- Market size by players – Top Companies
- Market size by product categories – Oral Drugs (Antibiotics, Antivirals, Antitubular, Antifungal) and Vaccines
- Market size by regions – North, South, East, West

$5,000.00
Opportunity in the Indian Cardiovascular Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Cardiovascular Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Date Published: Mar 6 2015

Opportunity in the Indian Cardiovascular Pharmaceuticals Market - 2015 report provides an insight into the Indian Cardiovascular Pharmaceuticals current market scenario, structure and practices.

In depth market scenario includes;
- Current market size estimate
- Market size by players – Top Companies
- Market size by product categories – Anti Hypertensives, ACE Inhibitors, Beta Blockers and Calcium Channel Blockers
- Market size by regions – North, South, East, West

$5,000.00
Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Date Published: Mar 6 2015

Opportunity in the Indian Biopharmaceuticals Market - 2015 report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices.

In depth market scenario includes;
- Indian Biopharmaceuticals Market Size
- Market share of key players – Top companies
- Market size for Vaccines
- Market size for Diagnostics
- Market size for Therapeutics
- Market size for Other Products

$6,000.00
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015

Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015

Date Published: Mar 1 2015
$3,500.00
The Generic Drugs Market: 2015 – 2030 - Opportunities, Challenges, Strategies & Forecasts

The Generic Drugs Market: 2015 – 2030 - Opportunities, Challenges, Strategies & Forecasts

Date Published: Feb 17 2015
A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights.
 
Already prevalent in the U.S., Europe and much of the developing world, generic drugs are now finding their way into previously untapped markets such as Japan, largely driven by regulatory efforts to reduce healthcare costs.
$2,500.00
Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Post-Myocardial Infarction. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Post-Myocardial Infarction.

$2,000.00
Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Chronic Heart Failure. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Chronic Heart Failure.

$2,000.00
Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Gastric Ulcers-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Gastric Ulcers. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Gastric Ulcers. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Gastric Ulcers.

$2,000.00
Influenza A Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Influenza A Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Influenza A Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Influenza A Infections. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Influenza A Infections.

$2,000.00
Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Tinea Versicolor (Cutaneous Mycoses)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tinea Versicolor (Cutaneous Mycoses). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Tinea Versicolor (Cutaneous Mycoses).

$2,000.00
Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Smallpox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Smallpox. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Smallpox. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Smallpox.

$2,000.00
Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Dyspnea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dyspnea. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dyspnea. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Dyspnea.

$2,000.00
Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Musculoskeletal Pain. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Musculoskeletal Pain.

$2,000.00
Myasthenia Gravis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Myasthenia Gravis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Myasthenia Gravis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Myasthenia Gravis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Myasthenia Gravis. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Myasthenia Gravis.

$2,000.00
Anterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Anterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Anterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Anterior Uveitis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Anterior Uveitis. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Anterior Uveitis.

$2,000.00
Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Bacterial Conjunctivitis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Bacterial Conjunctivitis.

$2,000.00
Head And Neck Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Head And Neck Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Date Published: Feb 5 2015

“Head And Neck Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Head And Neck Cancer. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Head And Neck Cancer.

$2,000.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data